Identification of the novel HLA-B*57:168 allele by next generation sequencing.
| Autor: | Du Z; Clinical Histocompatibility Laboratory, Department of Laboratory and Pathology, Mayo Clinic, Jacksonville, Florida, USA., Williams C; Clinical Histocompatibility Laboratory, Department of Laboratory and Pathology, Mayo Clinic, Jacksonville, Florida, USA., Santiago R; Clinical Histocompatibility Laboratory, Department of Laboratory and Pathology, Mayo Clinic, Jacksonville, Florida, USA., Ussery T; Clinical Histocompatibility Laboratory, Department of Laboratory and Pathology, Mayo Clinic, Jacksonville, Florida, USA., Elrefaei M; Clinical Histocompatibility Laboratory, Department of Laboratory and Pathology, Mayo Clinic, Jacksonville, Florida, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | HLA [HLA] 2024 Jan; Vol. 103 (1), pp. e15327. Date of Electronic Publication: 2023 Dec 11. |
| DOI: | 10.1111/tan.15327 |
| Abstrakt: | HLA-B*57:168 differs from HLA-B*57:01:01:01 by one nucleotide substitution at codon 325 (TGC > TCC) in exon 7. (© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text